We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Universal Display
OLED
$3.52B
| $943K | ﹤0.01% |
4,484
-148
| -3% | -$26K |
|
1127
H&R Block
HRB
$5.62B
| $939K | ﹤0.01% |
17,321
-1,185
| -6% | -$59K |
|
|
SKX
1128
DELISTED
Skechers
SKX
| $937K | ﹤0.01% |
13,553
-734
| -5% | -$48.6K |
|
1129
HealthEquity
HQY
$7.84B
| $936K | ﹤0.01% |
10,856
-381
| -3% | -$30.8K |
|
1130
Forestar Group
FOR
$1.34B
| $929K | ﹤0.01% |
29,036
+132
| +0.5% | +$4.47K |
|
|
PETQ
1131
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $925K | ﹤0.01% |
41,925
+241
| +0.6% | +$4.63K |
|
1132
Ardagh Metal Packaging
AMBP
$2.88B
| $924K | ﹤0.01% |
271,860
| – | – |
|
1133
Erie Indemnity
ERIE
$12.7B
| $923K | ﹤0.01% |
2,546
+144
| +6% | +$54.7K |
|
|
SWN
1134
DELISTED
Southwestern Energy Company
SWN
| $920K | ﹤0.01% |
136,698
-5,305
| -4% | -$38.7K |
|
|
X
1135
DELISTED
US Steel
X
| $919K | ﹤0.01% |
24,303
+3,361
| +16% | +$128K |
|
1136
Ingevity
NGVT
$2.34B
| $916K | ﹤0.01% |
+20,966
| New | +$1.01M |
|
1137
Aramark
ARMK
$15.2B
| $913K | ﹤0.01% |
26,851
-1,232
| -4% | -$40K |
|
1138
Forrester Research
FORR
$219M
| $906K | ﹤0.01% |
53,048
-14,784
| -22% | -$272K |
|
1139
Prothena Corp
PRTA
$434M
| $905K | ﹤0.01% |
+43,861
| New | +$949K |
|
1140
AnaptysBio
ANAB
$1.63B
| $904K | ﹤0.01% |
36,057
+16
| +0% | +$373 |
|
1141
Tiptree Inc
TIPT
$651M
| $902K | ﹤0.01% |
54,702
-7,197
| -12% | -$120K |
|
1142
Spectrum Brands
SPB
$1.99B
| $901K | ﹤0.01% |
10,480
+860
| +9% | +$74.7K |
|
|
SNBR
1143
DELISTED
Sleep Number
SNBR
| $899K | ﹤0.01% |
+93,944
| New | +$1.29M |
|
1144
First Industrial Realty Trust
FR
$8.23B
| $894K | ﹤0.01% |
18,807
-699
| -4% | -$33.5K |
|
|
SGI
1145
Somnigroup International
SGI
$13.8B
| $893K | ﹤0.01% |
18,853
+353
| +2% | +$17.9K |
|
1146
Toro Company
TTC
$8.79B
| $891K | ﹤0.01% |
9,530
-370
| -4% | -$32.6K |
|
1147
Chesapeake Utilities
CPK
$3.16B
| $885K | ﹤0.01% |
8,338
| – | – |
|
1148
BWX Technologies
BWXT
$13.4B
| $885K | ﹤0.01% |
9,319
-499
| -5% | -$46.3K |
|
1149
Akebia Therapeutics
AKBA
$253M
| $883K | ﹤0.01% |
865,252
-1,302
| -0.2% | -$1.61K |
|
1150
Encompass Health
EHC
$12.2B
| $881K | ﹤0.01% |
10,267
-2,727
| -21% | -$229K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.